Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies-Reference-Cited by-同舟云学术

Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies

Published:2004 Issue:1 Volume:101 Page:164-171
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chang Ting-Chang,Law Kim-Seng,Hong Ji-Hong,Lai Chyong-Huey,Ng Koon-Kwan,Hsueh Suei,See Lai-Chu,Chang Yu-Chen,Tsai Chien-Sheng,Chou Hung-Hsueh,Huang Kuan-Gen,Liou Jui-Der,Lin Cheng-Tao,Chao Angel,Chen Min-Yu,Wu Tzu-I,Ma Shih-Ya,Yen Tzu-Chen

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis

2. Outcome of recurrent cervical carcinoma following definitive irradiation

3. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma

4. Monitoring of Serum Squamous Cell Carcinoma Antigen Levels in Invasive Cervical Cancer: Is It Cost-Effective?

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is F18 FDG PET-CT an Authoritative Investigation as Compared to Other Conventional Imaging (CECT) Modality in Treated Cervical Cancer Patients?;Indian Journal of Gynecologic Oncology;2023-07-11

2. ROLE OF CONTEMPORARY IMAGING METHODS IN RADIOTHERAPY PLANNING AND MONITORING OF GYNECOLOGICAL CANCER PATIENTS (REVIEW);Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology;2023

3. Diagnostic Applications of Nuclear Medicine: Uterine Cancers;Nuclear Oncology;2022

4. Diagnostic Applications of Nuclear Medicine: Uterine Cancers;Nuclear Oncology;2022

5. Associations of whole-body 18F-FDG PET/CT parameters and SCC-Ag level with overall survival in patients with cervical cancer;Nuclear Medicine Communications;2021-10-05